TARDBP and amyotrophic lateral sclerosis: Taken together, C‐terminal phosphomimetic substitutions that mimic the phosphorylation pattern in ALS patients reduce the formation of SDS‐resistant high‐molecular‐weight oligomers and TDP‐43 aggregates in vitro.